BML Capital Management as of June 30, 2023
Portfolio Holdings for BML Capital Management
BML Capital Management holds 31 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 16.5 | $18M | 200k | 91.82 | |
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 16.3 | $18M | 180k | 100.63 | |
| Cyteir Therapeutics | 7.6 | $8.5M | 3.3M | 2.60 | |
| Atea Pharmaceuticals (AVIR) | 7.5 | $8.4M | 2.2M | 3.74 | |
| Adverum Biotechnologies | 7.4 | $8.2M | 5.2M | 1.59 | |
| Pardes Biosciences | 6.2 | $6.9M | 3.8M | 1.81 | |
| Talaris Therapeutics | 5.5 | $6.1M | 2.0M | 3.04 | |
| Athira Pharma (ATHA) | 4.9 | $5.5M | 1.9M | 2.95 | |
| Eliem Therapeutics (CLYM) | 4.0 | $4.4M | 1.6M | 2.80 | |
| Abercrombie & Fitch Cl A (ANF) | 4.0 | $4.4M | 118k | 37.68 | |
| Astrotech Corp (ASTC) | 2.8 | $3.1M | 220k | 14.16 | |
| Oramed Pharmaceuticals Com New (ORMP) | 2.7 | $3.0M | 850k | 3.58 | |
| Cortexyme (QNCX) | 1.9 | $2.1M | 1.4M | 1.50 | |
| Passage Bio (PASG) | 1.7 | $1.9M | 2.1M | 0.94 | |
| Forte Biosciences | 1.6 | $1.8M | 1.7M | 1.04 | |
| Enliven Therapeutics (ELVN) | 1.4 | $1.5M | 74k | 20.41 | |
| Arca Biopharma (ABIO) | 1.3 | $1.4M | 707k | 2.03 | |
| Tillys Cl A (TLYS) | 1.2 | $1.3M | 191k | 7.01 | |
| Lisata Therapeutics (LSTA) | 0.8 | $902k | 244k | 3.70 | |
| Verrica Pharmaceuticals (VRCA) | 0.8 | $866k | 150k | 5.77 | |
| Surrozen | 0.7 | $803k | 1.5M | 0.55 | |
| Milestone Pharmaceuticals (MIST) | 0.7 | $777k | 273k | 2.85 | |
| Retractable Technologies (RVP) | 0.7 | $769k | 669k | 1.15 | |
| Nextcure (NXTC) | 0.5 | $552k | 307k | 1.80 | |
| Graphite Bio | 0.4 | $396k | 152k | 2.60 | |
| Calcimedica Com New (CALC) | 0.3 | $356k | 89k | 4.01 | |
| Avrobio Ord (AVRO) | 0.2 | $244k | 256k | 0.95 | |
| Mei Pharma (MEIP) | 0.1 | $151k | 23k | 6.58 | |
| Adagio Therapeutics (IVVD) | 0.1 | $141k | 135k | 1.05 | |
| Rain Therapeutics | 0.1 | $88k | 73k | 1.20 | |
| Neoleukin Therapeutics | 0.0 | $20k | 24k | 0.83 |
